Abstract
Background The COVID-19 pandemic has posed unique challenges for cancer patients, who not only require ongoing medical care but also face an elevated risk of infection. Investigating the health-seeking behavior and barriers among adult cancer patients during this global crisis is crucial for ensuring their access to essential care amidst the pandemic’s complexities.
Objective This cross-sectional study aimed to assess the health-seeking behavior, perceived barriers, and anxiety among adult cancer patients during the COVID-19 pandemic.
Materials and Methods The study, conducted from August 2020 to December 2020, involved 210 participants purposively selected from the National Institute of Cancer Research and Hospital and Ahsania Mission Cancer and General Hospital in Dhaka. Data was collected through face-to-face interviews using a pre-tested semi-structured questionnaire and analyzed using SPSS (Version 26).
Results Among the 210 participants, 56.2% were male, 28.6% aged 46-55, and 36.7% had no formal education. Approximately 52.3% preferred public healthcare facilities, while 6.2% sought homeopathy or pharmacy advice for symptoms. Significant differences emerged in post-pandemic healthcare provider contact (p-0.0). Notably, 88.1% missed appointments, with 78.3% taking no action. Barriers included transport issues (77.1%), reduced income (59%), and lacking financial (53.4%) and mental support (56.6%). Conversely, respondents downplayed public awareness (80%), infection risk from others (84.7%), healthcare provider infection risk (82.4%), and hospital overcrowding (64.8%). Fear of hospitals correlated with public awareness (p-0.0). On the GAD-7 scale, most had minimal anxiety (53.8%), with a weak provider contact-anxiety correlation (p-0.03). Healthcare providers excelled in precautions (99.5%) and health status communication (85.3%).
Conclusion Despite the barriers and risks posed by the pandemic, cancer patients prioritized their care. Given the need for continued cancer care and the elevated risk of COVID-19 among cancer patients, adapting measures to align with the population’s real needs could prove highly beneficial.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board (IRB) of the National Institute of Preventive and Social Medicine (NIPSOM) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors